166 related articles for article (PubMed ID: 31456188)
1. Current State of Platinum Complexes for the Treatment of Advanced and Drug-Resistant Breast Cancers.
Biersack B; Schobert R
Adv Exp Med Biol; 2019; 1152():253-270. PubMed ID: 31456188
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.
Ott I; Gust R
Anticancer Agents Med Chem; 2007 Jan; 7(1):95-110. PubMed ID: 17266507
[TBL] [Abstract][Full Text] [Related]
3. Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.
Biersack B; Schobert R
Adv Exp Med Biol; 2016; 893():211-224. PubMed ID: 26667346
[TBL] [Abstract][Full Text] [Related]
4. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
5. Coinage metal complexes against breast cancer.
Biersack B; Ahmad A; Sarkar FH; Schobert R
Curr Med Chem; 2012; 19(23):3949-56. PubMed ID: 22780959
[TBL] [Abstract][Full Text] [Related]
6. The resurgence of platinum-based cancer chemotherapy.
Kelland L
Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
[TBL] [Abstract][Full Text] [Related]
7. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.
Lebwohl D; Canetta R
Eur J Cancer; 1998 Sep; 34(10):1522-34. PubMed ID: 9893623
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.
Uhm JE; Park YH; Yi SY; Cho EY; Choi YL; Lee SJ; Park MJ; Lee SH; Jun HJ; Ahn JS; Kang WK; Park K; Im YH
Int J Cancer; 2009 Mar; 124(6):1457-62. PubMed ID: 19065658
[TBL] [Abstract][Full Text] [Related]
9. Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials.
Petrelli F; Barni S; Bregni G; de Braud F; Di Cosimo S
Breast Cancer Res Treat; 2016 Dec; 160(3):425-437. PubMed ID: 27770282
[TBL] [Abstract][Full Text] [Related]
10. Platinum-based compounds for the treatment of metastatic breast cancer.
Shamseddine AI; Farhat FS
Chemotherapy; 2011; 57(6):468-87. PubMed ID: 22248721
[TBL] [Abstract][Full Text] [Related]
11. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
12. [Platinum-based chemotherapy in triple negative breast cancer].
Eckstein N; Haas B
Dtsch Med Wochenschr; 2012 Feb; 137(7):333-6. PubMed ID: 22318849
[TBL] [Abstract][Full Text] [Related]
13. Small cell lung cancer: defining a role for emerging platinum drugs.
Schiller JH
Oncology; 2002; 63(2):105-14. PubMed ID: 12239444
[TBL] [Abstract][Full Text] [Related]
14. The Renaissance of platinum-based chemotherapy for metastatic breast cancer.
Meriggi F; Di Biasi B; Zaniboni A
J Chemother; 2008 Oct; 20(5):551-60. PubMed ID: 19028616
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
[TBL] [Abstract][Full Text] [Related]
16. Evolution of chemotherapy with platinum compounds.
Walker EM; Walker SM
Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
[TBL] [Abstract][Full Text] [Related]
17. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.
Holloway RW; Mehta RS; Finkler NJ; Li KT; McLaren CE; Parker RJ; Fruehauf JP
Gynecol Oncol; 2002 Oct; 87(1):8-16. PubMed ID: 12468336
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.
Rottenberg S; Jaspers JE; Kersbergen A; van der Burg E; Nygren AO; Zander SA; Derksen PW; de Bruin M; Zevenhoven J; Lau A; Boulter R; Cranston A; O'Connor MJ; Martin NM; Borst P; Jonkers J
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17079-84. PubMed ID: 18971340
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
Ferguson PJ
J Otolaryngol; 1995 Aug; 24(4):242-52. PubMed ID: 8551538
[TBL] [Abstract][Full Text] [Related]
20. Polymeric drug delivery of platinum-based anticancer agents.
Haxton KJ; Burt HM
J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
